Protein serine/threonine phosphatase 2A (PP2A) activity must be tightly controlled to maintain cell homeostasis. Here, we report the identification of a previously uncharacterized mammalian protein, type 2A-interacting protein (TIP), as a novel regulatory protein of PP2A and the PP2A-like enzymes PP4 and PP6. TIP is a ubiquitously expressed protein and parallels the distribution of the PP2A catalytic subunit. Unlike its role in yeast, TIP does not interact with the mammalian homolog of type 2A-associated protein of 42 kDa (Tap42), a4, but instead associates with PP2A, PP4 and PP6 catalytic subunits independently of mammalian target of rapamycin kinase activity. Interestingly, the 20 kDa TIP splice variant TIP_i2, which lacks amino acids 173-272 of TIP's C-terminus, does not interact with PP2A; this finding indicates that residues 173-272 are important for the assembly of the TIP . phosphatase complex. In contrast to purified PP2A holoenzymes, TIP . PP2A complexes are devoid of phosphatase activity. Furthermore, alterations in the cellular levels of TIP influence the phosphorylation state of a specific protein substrate of ataxia-telangiectasia mutated (ATM)/ATM-and Rad3-related (ATR) kinases. Elevated levels of TIP result in an increase in the phosphorylation state of this protein substrate, whereas TIP-depleted cells exhibit a significant decrease in this protein's phosphorylation state, which is reversed by treatment with the PP2A inhibitor okadaic acid. These results indicate TIP is a novel inhibitory regulator of PP2A and implicate a role for TIP . PP2A complexes within the ATM/ATR signaling pathway controlling DNA replication and repair.
Introduction
Protein serine/threonine phosphatase 2A (PP2A) is an important regulator of numerous target proteins within diverse signaling pathways that underlie cell growth and proliferation, apoptosis, DNA replication, transcription and translation (Janssens and Goris, 2001) . It is well acknowledged that PP2A activity must be tightly controlled to maintain cell homeostasis; however, the molecular mechanisms that govern phosphatase activity in vivo remain poorly understood. Previous biochemical studies of PP2A have provided some insights into general modes of phosphatase regulation. The predominant form of PP2A within the cell is a heterotrimeric holoenzyme comprised of scaffolding (A), regulatory (B) and catalytic (C) subunits. Multiple B subunits, which have been grouped into four individual families (B, B 0 , B 00 and B 000 ), exist to target PP2A to distinct cellular compartments and/or substrates (McCright et al., 1996; Sontag et al., 1996; Strack et al., 1998) . Various post-translational modifications, (e.g. phosphorylation, carboxymethylation and ubiquitination) of the PP2A subunits can also influence the activity, oligomeric composition and intracellular levels of this enzyme (Chen et al., 1992; Bryant et al., 1999; Trockenbacher et al., 2001) . In addition, other cellular proteins (e.g. a4, PTPA, I1 PP2A and I2 PP2A ) can function as regulators of PP2A via direct association with the AC core dimer or free C subunit (Cayla et al., 1990; Li et al., 1995; Murata et al., 1997; Chen et al., 1998; Inui et al., 1998) .
The identification of PP2A-interacting proteins has proven to be an effective approach to uncover prospective phosphatase regulatory machinery. Indeed, recent discoveries of novel PP2A and PP2A-like protein complexes in Saccharomyces cerevisiae have provided a molecular framework for analogous studies of phosphatase regulation in mammalian systems Luke et al., 1996; Gavin et al., 2002; Van Hoof et al., 2005) . In the yeast target of rapamycin (TOR) nutrient signaling pathway, the association of type 2A-associated protein of 42 kDa (Tap42) with Sit4 and Pph21/22 (type 2A-related phosphatase catalytic subunits) yields an inactive phosphatase complex Jiang and Broach, 1999) , restraining phosphatase activity toward the downstream effectors nitrogen permease regulator 1 (NPR1) and glutamine metabolism 3 (GLN3) (Schmidt et al., 1998; Beck and Hall, 1999) . Although the mammalian homolog of Tap42, a4, has been shown to interact with the catalytic subunits of PP2A family members (PP2Ac, PP4c and PP6c), the effect of a4 on phosphatase activity remains controversial and appears to be substratedependent, as it has been shown to both enhance and inhibit PP2A (Murata et al., 1997; Inui et al., 1998) . Moreover, the stability of Tap42 Á phosphatase complexes is dependent on rapamycin-sensitive TOR kinase activity, whereas mammalian target of rapamycin (mTOR)-dependent regulation of the a4 Á phosphatase complex is in question (Murata et al., 1997; Chen et al., 1998; Kloeker et al., 2003) . Indeed, the role of a4 Á phosphatase complexes as downstream effectors of mTOR is itself dubious. Therefore, although some parallels exist between yeast and mammalian systems of phosphatase regulation, it is clear that the two systems are not identical.
Using a two-hybrid screen, Jacinto et al. (2001) recently described a novel yeast Tap42-interacting protein of 41 kDa (Tip41). Inactivation of TOR kinase (via rapamycin or low extracellular nitrogen levels) induces formation of a Tip41 Á Tap42 complex, which prevents Tap42's function to bind and inhibit Sit4 activity. Furthermore, deletion of the TIP41 gene promotes sustained Sit4 inactivation by Tap42 and results in hyperphosphorylation of the Sit4 substrate NPR1. Thus, Tip41 appears to negatively regulate the yeast TOR pathway by indirectly functioning as a positive regulator of phosphatase activity.
In the present studies, we cloned the human homolog of Tip41 to explore a potential interaction of the mammalian Tip41 protein (TIP) and a4. Surprisingly, although no evidence for a TIP Á a4 complex was found, we discovered that TIP interacts with PP2Ac, PP4c and PP6c. A 20 kDa splice variant of TIP (TIP_i2) lacking determinants for phosphatase binding was also identified. Our findings indicate that TIP, but not TIP_i2, functions as an inhibitory regulator of PP2A-like enzymes. Consistent with this idea, TIP-depleted cells and cells overexpressing TIP exhibited a significant decrease and increase, respectively, in the phosphorylation of a 32 kDa target protein substrate of Ataxia-telangiectasia mutated (ATM)/ATM-and Rad3-related (ATR) kinases. Together these studies illustrate differences between the mammalian and yeast systems of PP2A regulation and support a role for TIP Á phosphatase complexes in the regulation of DNA replication and repair.
Results and discussion
Gene structure and analysis of TIP protein expression Jacinto et al. (2001) Figure 1a) . TIP_i2 is a C-terminal truncation of TIP, comprised of amino acids 1-172 and ending with a unique six amino-acid stretch 'PGGGHL'.
To characterize the expression pattern of TIP, we utilized an affinity-purified rabbit polyclonal antibody recognizing the C-terminus of this protein. This antibody recognized a protein of B33 kDa in several cell lines representative of various human tissues (Supplementary Figure 1b) . Additional biochemical analyses firmly established that the 33 kDa protein is endogenous TIP (Supplementary Figure 1 legend) . Immunoblot analysis of the panel of mammalian cell lysates revealed a fairly ubiquitous expression pattern for TIP (Supplementary Figure 1b) , which is consistent with the ubiquitous expression profiles of a4, PP2Ac, PP4c and PP6c (Kloeker et al., 2003) .
TIP does not interact with a4 but binds PP2Ac in a rapamycin-independent manner Studies performed in S. cerevisiae have revealed a physical interaction between yeast Tip41 and Tap42 that is enhanced following treatment with the TOR kinase inhibitor rapamycin (Jacinto et al., 2001) . To determine whether TIP physically interacts with a4, we introduced myc-a4 and FLAG-TIP into HEK293 cells and performed reciprocal immunoprecipitations from the cell lysates. Unlike their yeast counterparts, treatment with rapamycin did not induce the formation of a TIP Á a4 complex (Figure 1a and b, lanes 5 and 6). In fact, we did not find any evidence for the existence of a TIP Á a4 complex; this observation is consistent with a recent report demonstrating that TIP failed to interact with a4 in in vitro binding experiments (Gingras et al., 2005) . Also consistent with a previous report from our laboratory (Kloeker et al., 2003) , PP2Ac coimmunoprecipitated with a4 in a rapamycin-independent manner ( Figure 1a, lanes 3 and 4) . Unexpectedly, we detected PP2Ac in TIP immune complexes (Figure 1b , lanes 3 and 4), but not in control immunoprecipitations (Figure 1b, lanes 1 and 2) , thus demonstrating the specificity of the TIP Á PP2Ac interaction. Neither rapamycin treatment nor coexpression with a4 affected the levels of endogenous PP2Ac coimmunoprecipitating with TIP ( Figure 1b, lanes 3-6) . Likewise, TIP overexpression did not have any significant effect on the levels of endogenous PP2Ac coimmunoprecipitating with a4 ( Figure 1a , lanes 3-6). Therefore, it appears that a4 and TIP do not compete for binding to the same cellular pool of PP2Ac, and that a4 Á PP2Ac and TIP Á PP2Ac complexes are formed independently. Furthermore, as the A subunit was not detected in the isolated TIP Á PP2Ac complexes (not shown), the association of TIP with PP2Ac is likely direct -analogous to the a4 Á PP2Ac interaction (Murata et al., 1997) .
The C-terminus of TIP is important for its interaction with PP2A To determine whether TIP_i2 binds PP2Ac, we transfected cells with either FLAG-TIP_i2 or FLAG-TIP and probed isolated FLAG immune complexes for PP2Ac. The results from these experiments revealed that PP2Ac interacts with TIP, but not with TIP_i2 ( Figure 2a) . Consistent with the results shown in Figure 1 , rapamycin did not affect the TIP Á PP2Ac complex or induce a TIP_i2 Á PP2Ac complex (Figure 2a ). Rapamycin did, however, induce the expected dephosphorylation of phospho-T389 p70S6 kinase, thus demonstrating the efficacy of rapamycin under these experimental conditions. The inability of TIP_i2 to bind PP2Ac indicates that C-terminal residues 173-272 of TIP are important for binding PP2Ac (Figure 2b) . Notably, this putative PP2Ac-binding region is the most conserved region of TIP in mammals, sharing 89% identity and 93% similarity in amino-acid sequences (Supplementary Figure 2) . The identification of a TIP splice variant that does not interact with PP2A suggests that TIP and TIP_i2 perform disparate intracellular functions, which may directly affect the formation and/or subcellular localization of TIP Á phosphatase complexes. Moreover, these findings indicate that alternative splicing may provide an additional mechanism for TIP-dependent modulation of PP2A in mammalian cells.
TIP also interacts with PP4c and PP6c
Despite the high homology of PP2A family members (60-65% amino-acid sequence identity (Kloeker et al., 2003) ), the catalytic subunits do not share the same structural or targeting subunits (Kloeker and Wadzinski, 1999; Wada et al., 2001) . They do, however, have one common binding partner -a4 (Chen et al., 1998; Nanahoshi et al., 1998) . As our findings revealed an interaction between TIP and PP2Ac (Figure 1b) , it seemed plausible that TIP might also form independent complexes with PP4c and PP6c. To address this question, we immunoprecipitated FLAG-TIP and FLAG-a4 complexes from cell lysates and probed them for endogenous PP4c and PP6c. Like PP2Ac, both PP4c and PP6c interacted with TIP ( Figure 3) ; these findings are consistent with a recent report demonstrating that TIP interacts with PP2A-like catalytic subunits in in vitro binding assays (Gingras et al., 2005) . In contrast, the PP1 catalytic subunit failed to interact with TIP or a4 (not shown), illustrating the specificity of these interactions. Interestingly, the level of all three phosphatase catalytic subunits associated with TIP was higher than those associated with a4, suggesting that TIP Á phosphatase complexes are more abundant in the cell than a4 Á phosphatase complexes. These results support a universal regulatory function for TIP as a binding partner of PP2A family members.
To verify the existence of endogenous TIP Á phosphatase complexes, immunoprecipitations were performed from HEK293 cell lysates using a polyclonal TIP antibody. As shown in Figure 3b , PP2Ac, PP4c and PP6c were detected in the TIP immune complexes but not in the control immunoprecipitations. These data confirm an interaction between endogenous TIP and the catalytic subunits of PP2A family members, and also suggest that TIP Á phosphatase complexes are quite stable.
TIP is an inhibitor of PP2Ac activity
To explore the physiological role of TIP as a modulator of phosphatase function, we tested whether immuno- Figure 1 TIP binds PP2Ac in a rapamycin-independent manner. HEK293 T-Rex cells were transfected with empty vector (EV), myc-a4 (a4), FLAG-TIP (TIP) or myc-a4 and FLAG-TIP (a4 þ TIP). At 24 h post-transfection, cells were treated with 1mg/ml tetracycline for an additional 24 h. Cells were then treated with ( þ ) or without (À) 0.2 mM rapamycin for 20 min. Myc and FLAG immune complexes were isolated from the resulting cell lysates, and bound proteins were eluted with SDS sample buffer. Top panels, Myc (a) and FLAG M2 (b) immune complexes were analysed by SDS-PAGE and immunoblotting with monoclonal antibodies recognizing myc, FLAG and PP2Ac. Normalization of PP2Ac levels to the levels of FLAG-TIP or myc-a4 revealed no significant changes7rapamycin. Bottom panels, aliquots of the lysates (B30 mg of protein) were analysed by SDS-PAGE and immunoblotting with the same antibodies.
purified FLAG-TIP influences the catalytic activity of purified PP2Ac. Incubation of FLAG-TIP with PP2Ac resulted in a dose-dependent decrease in phosphatase activity ( Figure 4a ). In contrast to TIP, similar concentrations of TIP_i2 did not have any significant effect on PP2Ac activity (not shown). Although complete inhibition of phosphatase activity was not observed, the data clearly demonstrate that TIP induces a statistically significant decrease in PP2Ac activity. One possible explanation for the incomplete inhibition is that the TIP protein purified from HEK293 cells may not be fully active. Various post-translational modifications and/or protein-protein interactions could give rise to a mixed population of active and inactive forms of TIP, thereby reducing the inhibitory potential of the purified TIP preparation. The incomplete inhibition could also be owing to heterogeneity within the purified PP2Ac preparation. PP2Ac is the target of several posttranslational modifications (Janssens and Goris, 2001 ); however, it remains to be determined whether any of these modifications influences the sensitivity of PP2Ac to inhibition by TIP.
As an alternative approach to explore TIP's modulation of PP2A function, we examined endogenous phosphatase activities associated with FLAG-TIP and FLAG-Ba complexes. Mammalian expression plasmids encoding FLAG-TIP and FLAG-Ba were transfected into HEK293 cells and the FLAG-tagged complexes were purified side-by-side from the corresponding cell lysates. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and silver stain analysis of the complexes revealed highly purified protein preparations (Figure 4b ). The identity of TIP, A, Ba and C was confirmed by immunoblot analysis (not shown). The amount of PP2A catalytic subunit in each preparation was quantified and the samples were adjusted to contain equal amounts of catalytic subunit before measurement of phosphatase activities. ABaC holoenzymes exhibited a dose-dependent increase in activity, whereas TIP Á PP2Ac complexes did not display any phosphatase activity at equivalent concentrations of catalytic subunit (Figure 4c ). Direct comparison of endogenous phosphatase activities associated with TIP and Ba complexes, using either a small molecule substrate or phosphorylated histone (Figure 4c TIP restrains PP2A's activity toward an ATM/ATR substrate Recent advances in RNAi technology have promoted its use as a powerful strategy to define cellular substrates for specific oligomeric forms of PP2A (Adams et al., 2005) . To examine TIP's cellular function in PP2A-controlled signaling pathways, we asked whether depletion or overexpression of TIP in mammalian cells would affect the phosphorylation status of PP2A substrates (see Figure 5a for analysis of TIP levels in these cells). Because a plethora of PP2A substrates have been identified, and presumably many more remain undiscovered, we surveyed changes in protein phosphorylation using phospho-serine/threonine antibodies recognizing specific kinase substrate motifs. HEK293 cells containing control or TIP siRNAs were lysed in the presence of phosphatase inhibitors, and the resulting cell lysates were analysed by SDS-PAGE and immunoblot using phospho-serine/threonine Akt, PKC, PKA, MAPK/CDK, CDK and ATM/ATR substrate antibodies (Figure 5b-e and not shown) . The ATM/ATR substrate antibody, which recognizes phospho-S/T-Q motifs, revealed the most significant, TIP-dependent change in protein phosphorylation. A similar effect was also achieved using another siRNA oligonucleotide targeting a different region of TIP (not shown). As shown in Figure 5b , a substantial decrease in the phosphorylation of a 32kDa protein occurred in TIP-depleted cells as compared to mock-treated cells or cells transfected with control siRNA. Conversely, TIP overexpression in HEK293 cells resulted in increased phosphorylation of the same 32 kDa protein. These findings are consistent with the hypothesis that TIP functions as a PP2A inhibitor, because its absence in cells triggers increased protein dephosphorylation (hypophosphorylation), and its overexpression promotes decreased protein dephosphorylation (hyperphosphorylation). These intriguing results invoke two plausible targets for TIP-regulated PP2A activity: the 32 kDa phosphoprotein substrate of ATM/ATR and/or the ATM/ATR kinases themselves. Previous reports describing PP2A's involvement within the ATM/ATR-regulated DNA damage and repair pathway provide support for both possibilities (Goodarzi et al., 2004; Petersen et al., 2006) . Goodarzi et al. (2004) reported a biochemical interaction of ATM and the PP2A core dimer in human lymphoblastoid cells. Interestingly, although they demonstrated that the PP2A inhibitor okadaic acid induced the autophosphorylation of ATM on serine-1981, there was no corresponding increase in ATM activity. Increased ATM activity was detected only upon treatment of cells with ionizing radiation. As we did not use ionizing radiation, it is unlikely that the observed effects on the phosphorylation of the 32 kDa protein (Figure 5b ) are owing to a direct TIP-dependent inhibition of PP2A activity towards ATM kinase. Consistent with this idea, a report by Petersen et al. (2006) found no evidence for PP2A regulation of ATM or ATR activity in experiments using Xenopus egg extracts. Instead, they demonstrated that PP2A and ATM/ATR act as opposing forces to control the balance of phosphorylation toward an unknown factor involved in DNA checkpoint regulation. This is an attractive hypothesis, because PP2A's ability to directly dephosphorylate phospho-S/T-Q motifs has been demonstrated in several proteins including Chk1 (Petersen et al., 2006) , Chk2 (Dozier et al., 2004) , SV40 large T antigen (Scheidtmann et al., 1991) , and p53 (Scheidtmann et al., 1991) . On the basis of these collective observations, we postulate that TIP-regulated PP2A directly targets the phospho-S/T-Q motif within the 32 kDa ATM/ATR substrate protein for dephosphorylation. To characterize whether this protein is a bona fide substrate of ATM or ATR kinases, control and TIP-depleted cells were treated with caffeine, a potent inhibitor of both ATM and ATR activity (Sarkaria et al., 1999) . As shown in Figure 6a and d, caffeine abolished the phospho-signal of the 32 kDa band (Figure 6a , lanes 2, 4 and 6 and Figure 6d , lanes 3, 6 and 9), demonstrating that ATM and/or ATR kinase activity directly affects the phosphorylation state of this protein. Both caffeine treatment and TIP-depletion, that is inhibiting kinase activity and 'activating' phosphatase activity, resulted in the decreased phosphorylation of this protein. To determine whether decreased TIP levels would have a more global effect on protein phosphorylation, we analysed TIPdepleted extracts using a phospho-threonine antibody ( Figure 6a) . As compared to control cells, neither caffeine nor TIP-depletion had a significant effect on global threonine phosphorylation. Next, we asked whether decreased levels of TIP affected the phosphostates of other established ATM/ATR substrates, namely Chk1 and Chk2. As shown in Figure 6b , the phosphorylation of Chk2 was unaffected by TIP , FLAG-TIP (TIP) or FLAG-a4 and treated with tetracycline as described in the legend for Figure 2 . Cell lysates were incubated with anti-FLAG M2 agarose beads, and bound proteins were eluted with FLAG peptide. FLAG peptide eluates were analysed by SDS-PAGE and immunoblotting with FLAG M2, PP2Ac, PP4c and PP6c antibodies. (b) Untransfected HEK293 lysates were incubated with a TIP polyclonal antibody or normal rabbit IgG, followed by incubation with Protein G-Sepharose beads. Antibody Á protein complexes were eluted and analysed by SDS-PAGE and immunoblotting using TIP, PP2Ac, PP4c and PP6c antibodies. Whole-cell lysates (WCL) were analysed by SDS-PAGE and immunoblotting using the same antibodies.
depletion (compare lanes 1, 3 and 5), whereas treatment with caffeine decreased levels of phospho-Chk2 (compare lanes 1 vs 2, 3 vs 4, 5 vs 6). Cellular levels of phospho-Chk1 were also unaffected by altered TIP expression (not shown).
To ensure that changes in phosphorylation of the S/T-Q motif within this unidentified 32 kDa protein are a direct consequence of altered PP2A activity, and not owing to changes in protein abundance, we examined the ability of the PP2A inhibitor okadaic acid to influence its phosphorylation. Indeed, treatment of HEK293 cells with okadaic acid induced a timedependent increase in phosphorylation of the 32 kDa protein substrate of ATM/ATR (Figure 6c ). Inhibition of cellular PP2A using fostriecin, which is 10 000-fold more selective for PP2A than PP1 (Walsh et al., 1997) , yielded equivalent results (not shown). We also examined the effects of okadaic acid treatment on the phosphorylation of the 32 kDa protein in mock-transfected cells and cells transfected with control or TIP siRNA.
As shown in Figure 6d , okadaic acid induced a robust phosphorylation of the 32 kDa protein in all three cell types (lanes 2, 5 and 8). Importantly, treatment of TIPdepleted cells with okadaic acid prevented dephosphorylation of this protein (compare lanes 4 and 5), illustrating that TIP directly affects PP2A activity toward this specific protein. The opposing effects on phosphorylation of the 32 kDa protein in cells lacking a cellular PP2A inhibitor (TIP) versus cells treated with a chemical PP2A inhibitor (okadaic acid) or cells overexpressing TIP (Figures 5b, 6a, c and d) , together with the results of the phosphatase assays (Figure 4) , demonstrate that TIP is indeed a physiologic inhibitor of PP2A activity.
In summary, our studies indicate that TIP, but not its splice variant TIP_i2, directly interacts with and restrains the activity of PP2A-like enzymes. We also describe a cellular function for TIP within the ATM/ ATR signaling pathway, and implicate a target (i.e. the 32 kDa protein substrate of ATM/ATR) for Cell lysates were incubated with anti-FLAG M2 agarose beads for 4 h at 41C and bound proteins were eluted with FLAG peptide. Silver stain analysis was performed on the FLAG eluates from mock (M), FLAG-Ba (ABC) or FLAG-TIP (TIP Á C) immune complexes. An equivalent amount of catalytic subunit (7.2 ng) was present in the ABaC and TIP Á C preparations. *Denotes nonspecific bands. (c) Top panel, the indicated amounts of PP2A catalytic subunit contained within the ABaC and TIP Á C preparations were continuously assayed for phosphatase activity using DiFMUP as a substrate. Background (eluates from mock-transfected cell immunoprecipitations) was measured and subtracted from absolute fluorescent values. Levels of fluorescence in TIP Á C preparations were virtually identical to levels of fluorescence in control reactions (background). The data represent the mean7s.e.m. from three independent experiments. Standard error bars are obscured by the symbols for most data points. r 2 ¼ 0.9949, 0.9962 and 0.9948 for 2.4, 4.8 and 7.2 ng C subunit, respectively. Bottom panel, quantitation of phosphatase activity at the 600 s time point. **Represents significant differences (Po0.0001) based on two-tailed t-tests.
TIP-regulated PP2A activity. Together, these results highlight important differences between yeast and metazoan systems for regulation of PP2A-like enzymes. Although the cellular roles of TIP and a4 may not be conserved from yeast to humans, it is clear that a more general role of these proteins as PP2A regulators is a commonality between yeast and man. Yeast Tip41 indirectly functions as a positive modulator of PP2A-like phosphatases in the yeast TOR signaling pathway (Jacinto et al., 2001) , whereas TIP binds and inhibits PP2A-like enzymes that oppose ATM/ATR-dependent phosphorylation events. Interestingly, both TOR and ATM/ATR kinases are members of the same family of PI-3-like kinases, and are integral players in cell-cycle checkpoint regulation (Abraham, 2001) . Further elucidation of TIP-dependent inhibition of PP2A activity toward the 32 kDa ATM/ATR substrate, as well as the identification of this protein, will provide novel insight into the regulation of mammalian DNA replication/ repair processes. The loss of cell-cycle checkpoint control is a characteristic of many human tumors, and pharmacologic interference of ATM/ATR activity has been suggested as a potential therapy for combating cancers resistant to conventional DNA-damaging agents (Abraham, 2001) . Alternatively, the opposing force controlling reversible phosphorylation within these signaling pathways, the phosphatase, is also a viable target for pharmacologic intervention. Loss of TIP function may lead to unchecked PP2A activity, resulting in hypophosphorylation of a specific substrate of ATM/ ATR. To this end, the identification of specific phosphatase regulatory proteins (e.g. TIP) that function within signaling pathways important for DNA replication and repair may provide additional targets for cancer drug development.
Materials and methods
Antibodies and reagents TIP rabbit antibodies were from Bethyl Laboratories Inc.
(Montgomery, TX, USA). Affinity-purified a4, PP4c and PP6c antibodies were described previously (Kloeker et al., 2003) . Polyclonal and monoclonal FLAG antibodies were from Sigma (St Louis, MO, USA), and mouse c-myc antibody was from BD Biosciences Clontech (Palo Alto, CA, USA). The monoclonal PP2Ac and p70S6K antibodies were from BD Biosciences Pharmingen (San Diego, CA, USA). GAPDH monoclonal antibody was from Abcam Inc. (Cambridge, MA, USA). Phospho-p70S6K (T389), phospho-threonine, phospho-Chk2 (S68) and Chk2 antibodies, and the phospho-(ser/ thr) kinase substrate antibody kit were from Cell Signaling Technology (Beverly, MA, USA). Targeted and control duplex siRNA oligonucleotides were manufactured by Invitrogen Lysates were generated in the presence of phosphatase inhibitors, and equal amounts of protein were analysed by SDS-PAGE and immunoblotting using antibodies recognizing phospho-(ser/thr)ATM/ATR substrates, phospho-threonine, PP2Ac and TIP. The blots were also probed for PP2Ac as a loading control. (b) HEK293 T-Rex cells were transfected as described in (a). Lysates were analysed by SDS-PAGE and immunoblotting using p-S68 Chk2, Chk2 and TIP antibodies. (c) Following serum starvation (1 h), HEK293 cells were incubated with 1 mM okadaic acid for the indicated times. Lysates were subjected to immunoblot analysis using phospho-(ser/thr)ATM/ATR substrate and GAPDH antibodies.
(d) HEK293 T-Rex cells were transfected as described in (a). Thirty min before harvesting, cells were incubated with ( þ ) or without (À) 1 mM okadaic acid or 5 mM caffeine. Lysates were analysed by SDS-PAGE and immunoblotting using phospho-(ser/thr)ATM/ ATR substrate, PP2Ac and TIP antibodies.
(Carlsbad, CA, USA); see Supplementary Methods for siRNA sequences. Lysates from A375, MCF-7, T98G, Hep-2, HCT-116 and Ramos cell lines were from Imgenex (San Diego, CA, USA). The cloning and plasmid construction of TIP, TIP_i2 and a4 cDNAs are described in Supplementary Methods.
Cell culture and transfection HEK293 T-Rex cells (Invitrogen) stably expressing the tetracycline repressor protein were grown at 371C in a humidified atmosphere with 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and 5 mg/ml blasticidin (Invitrogen). Cells were transfected with the tetracycline-inducible expression vectors using Fugene 6 (Roche, Indianapolis, IN, USA) according to manufacturer's directions. For generation of tetracycline-inducible stable cell lines, HEK293 T-Rex cells were transfected with pcDNA5TO or FLAG-TIP/pcDNA5TO and selected in medium containing 175 mg/ml hygromycin B. For inducible protein expression, cells were treated with 1 mg/ml tetracycline (Sigma) and incubated at 371C for the indicated amount of time.
Transfections with siRNA were performed using Dharmafect reagent (Dharmacon, Lafayette, CO, USA) according to manufacturer's directions. Following a 48 h incubation, siRNA-transfected cells were serum-starved overnight and lysed in buffer A (20 mM Tris-HCl, pH 7.2, 2 mM EGTA, 5 mM EDTA, 30 mM NaF, 0.5% Igepal, 20 mM sodium pyrophosphate, 40 mM b-glycerophosphate, 1 mM sodium orthovanadate, 1 mM microcystin-LR, 1 mM phenylmethanesulfonyl fluoride (PMSF), 5 mM pepstatin A and 1 mg/ml leupeptin). For experiments with okadaic acid and caffeine, HEK293 cells were first serum-starved and then incubated at 371C with 1 mM okadaic acid (Alexis Biochemicals, San Diego, CA, USA) or 5 mM caffeine (Sigma) for the indicated amount of time. For experiments including rapamycin, cells were incubated with 0.2 mM rapamycin (Alexis Biochemicals) for 20 min immediately before lysis.
Coimmunoprecipitations
For immunoprecipitations using antibody-conjugated agarose beads, cells were lysed in immunoprecipitation (IP) buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Igepal, 5 mg/ml aprotinin, 1 mg/ml pepstatin A, 1 mM PMSF and 1 mg/ml leupeptin) and centrifuged for 10 min at 12 000 g. Clarified lysates were incubated with 20 ml of a 50% slurry of anti-FLAG M2-agarose (Sigma) or 20 ml of a 50% slurry of anti-mycagarose (Clontech) for 2-18 h at 41C. After three washes in IP buffer, bound proteins were eluted in SDS sample buffer and subjected to Western analysis. In some experiments, bound proteins were eluted from the anti-FLAG resin by incubation for 30 min at 41C with 100 mg/ml FLAG peptide in 50 ml of Tris-buffered saline (25 mM Tris-HCl, pH 7.4, 137 mM NaCl, 3 mM KCl); the elution was repeated and the eluates were pooled. For immunoprecipitations using unconjugated antibodies, cells were lysed in buffer B (20 mM Tris-HCl, pH 7.6, 0.1% Igepal, 150 mM NaCl, 3 mM EDTA, 3 mM EGTA, 5mg/ml aprotinin, 1 mg/ml pepstatin A, 1 mM PMSF and 1 mg/ml leupeptin) and centrifuged for 10 min at 12 000 g. Clarified lysates were incubated overnight at 41C with 2 mg of rabbit polyclonal TIP antibody or 2 mg of rabbit polyclonal control IgG, and subsequently incubated for 1 h with 20 ml of a 50% slurry of Protein G-Sepharose beads (Zymed, San Francisco, CA, USA). Bound complexes were washed three times with the lysis buffer, eluted in SDS sample buffer, and then subjected to Western analysis. For a detailed description of Western analysis, see Supplementary Methods.
Purification of TIP Á PP2Ac and ABaC complexes, and measurement of phosphatase activity Immunopurified phosphatase complexes (TIP Á C and ABaC) were normalized for equal amounts of catalytic subunit and diluted with phosphatase assay buffer (50 mM Tris-HCl, pH 7.0, 0.1 mM CaCl 2 and 3.2 mg/ml bovine serum albumin). For some experiments, 1.4 pmol of purified PP2Ac (Globozymes, Carlsbad, CA, USA) was incubated with the indicated amounts of immunopurified FLAG-TIP protein and then diluted with phosphatase assay buffer. Phosphatase assays were performed using the fluoregenic substrate 6,8 difluoro-4-methylumbelliferyl phosphate (DiFMUP; Molecular Probes, Eugene, OR, USA) or PKA-phosphorylated histone H1. See Supplementary Methods for a more detailed description of the phosphatase assays.
Abbreviations
PP2A, protein serine/threonine phosphatase 2A; PP4, protein serine/threonine phosphatase 4; PP6, protein serine/threonine phosphatase 6; PP1, protein serine/threonine phosphatase 1; TIP, type 2A-interacting protein; TIP_i2, 20 kDa splice variant of TIP; Tap42, type 2A-associated protein of 42 kDa; mTOR, mammalian target of rapamycin; ATM, ataxia-telangiectasia mutated; ATR, ATM-and Rad3-related.
